State Street’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-695
Closed -$4.61K 4319
2025
Q4
$4.61K Hold
695
﹤0.01% 4282
2025
Q3
$9.03K Hold
695
﹤0.01% 4270
2025
Q2
$12.5K Hold
695
﹤0.01% 4234
2025
Q1
$15K Hold
695
﹤0.01% 4231
2024
Q4
$13.1K Hold
695
﹤0.01% 4264
2024
Q3
$25.6K Hold
695
﹤0.01% 4196
2024
Q2
$17K Sell
695
-4
-0.6% -$199 ﹤0.01% 4287
2024
Q1
$44.9K Hold
699
﹤0.01% 4181
2023
Q4
$86.4K Buy
699
+74
+12% +$8.72K ﹤0.01% 4079
2023
Q3
$82.9K Hold
625
﹤0.01% 4156
2023
Q2
$115K Sell
625
-76
-11% -$15.2K ﹤0.01% 4200
2023
Q1
$118K Hold
701
﹤0.01% 4267
2022
Q4
$151K Hold
701
﹤0.01% 4225
2022
Q3
$271K Sell
701
-22
-3% -$12.5K ﹤0.01% 4007
2022
Q2
$304K Sell
723
-2,603
-78% -$1.26M ﹤0.01% 4024
2022
Q1
$1.98M Buy
3,326
+269
+9% +$200K ﹤0.01% 3571
2021
Q4
$3.38M Sell
3,057
-2,842
-48% -$6.18M ﹤0.01% 3430
2021
Q3
$22.7M Buy
5,899
+3,243
+122% +$10.2M ﹤0.01% 2390
2021
Q2
$7.65M Buy
2,656
+808
+44% +$1.91M ﹤0.01% 3046
2021
Q1
$3.69M Buy
1,848
+709
+62% +$1.07M ﹤0.01% 3177
2020
Q4
$1.09M Buy
1,139
+213
+23% +$182K ﹤0.01% 3538
2020
Q3
$742K Buy
926
+132
+17% +$117K ﹤0.01% 3508
2020
Q2
$754K Buy
+794
New +$794K ﹤0.01% 3477

Other funds holding PAVM

State Street's PAVM Position: Q1 2026 in Review

State Street sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 695 shares — an estimated $4.61K sold.

State Street first reported a position in PAVM in Q2 2020 and held it in 23 quarters. The position peaked at $22.7M in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • State Street reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • State Street sold 695 PAVmed shares in Q1 2026, an estimated $4.61K.
  • State Street first reported a position in PAVmed in Q2 2020 and held it in 23 quarters.
  • State Street's PAVmed position peaked at $22.7M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.